
TL;DR: Antibiotic resistance means bacteria no longer respond to an antibiotic, not that your body has become resistant, as the World Health Organization explains.
Key takeaways
- Antibiotic resistance concerns bacteria; antimicrobial resistance is the broader term covering resistance in bacteria, viruses, fungi and parasites, according to the WHO fact sheet.
- Antibiotics have no effect on viruses, including those responsible for colds and flu, as WHO's public information explains.
- WHO's global resistance estimates concern laboratory-confirmed bacterial infections, not the chance that any particular Dubai resident has a resistant infection, as the 2025 surveillance announcement makes clear.
- mescreen™'s UAE product description identifies a non-diagnostic wellness assessment, not a test for infection or antibiotic resistance.
What does antibiotic resistance actually mean?
Antibiotic resistance means bacteria have changed in ways that make an antibiotic ineffective against them. WHO's explanation of the common misconception is explicit: bacteria become resistant, not the person taking the medicine.
The broader term, antimicrobial resistance, includes viruses, fungi and parasites no longer responding to their respective medicines. Antibiotics, antivirals, antifungals and antiparasitics are different categories, as the WHO fact sheet explains.
That distinction matters when reading a headline. A story about antimicrobial resistance is not automatically a story about every antibiotic, every infection or every person in the UAE. Health terminology already has enough committee meetings without making every term do three jobs.

Why does this matter in Dubai and the Gulf?
Antimicrobial resistance is an established regional health-policy concern, not simply a problem discussed in overseas headlines. The Ministry of Health and Prevention's account of its 2025 Dubai conference describes sessions on resistance in GCC countries, regional cooperation and antibiotic stewardship, meaning efforts to use antibiotics appropriately.
The wider issue is not confined to prescribing. WHO identifies inappropriate antibiotic use, inadequate infection control, poor access to water and sanitation, and limited access to diagnostics and medicines among the factors driving resistance. It also states that resistance spreads across borders.
For UAE readers, our editorial judgement is that the useful question is not whether the Gulf is somehow exempt. It is whether a claim distinguishes regional surveillance, local evidence and an individual's clinical situation. Those are three different levels of information, not three interchangeable headlines.
Does the global headline describe your personal risk?
No. A resistance estimate among laboratory-confirmed infections is not a personal risk score for a reader in Dubai.
In its 2025 surveillance announcement, WHO reported that one in six laboratory-confirmed bacterial infections causing common infections worldwide in 2023 were resistant to antibiotic treatments. The announcement covers specified bacteria and infection types. It also notes substantial gaps in reporting and surveillance capacity.
The distinction is the denominator: the group being counted. These data describe infections included in surveillance, not everyone living in a city, everyone with a cough or everyone who has previously taken an antibiotic. A global finding cannot simply be relabelled as a Dubai prevalence figure.

A large number deserves attention. It does not come with permission to change its meaning for a more dramatic headline.
What does UAE research tell us about self-medication?
A UAE study documents self-reported use of antibiotics without a prescription, but it does not establish today's national rate or measure antibiotic resistance itself.
A cross-sectional study published in 2019 surveyed 315 participants in Abu Dhabi, Dubai and Sharjah. It reported that 31.7% had used non-prescription antibiotics. This was questionnaire-based research, not laboratory testing of resistant bacteria.
The study offers historical local context for discussing self-medication. It cannot tell us how common that behaviour is in the UAE today, establish what caused an individual's infection, or quantify that person's resistance risk. The date, design and outcome measured belong alongside the percentage, not in the small print.
Does avoiding unnecessary antibiotics mean avoiding all antibiotics?
No. Responsible use concerns appropriate access and use, not a blanket argument against antibiotics.
The WHO fact sheet identifies taking antibiotics when they are not needed, or taking the wrong type, as examples of misuse. It also identifies inadequate access to appropriate diagnostics and medicines as part of the wider problem. The message is not that antibiotics are inherently undesirable.
For a consultation, useful questions include: What is the medicine intended to address? What evidence supports that assessment? Would testing change the decision? Who should explain the instructions and follow-up? These are prompts for a conversation with a licensed clinician or pharmacist, not a way to select or change medication yourself.

This article does not advise starting, stopping, sharing, replacing or shortening any medicine. Decisions about an existing prescription belong with the prescribing professional.
Can a wellness assessment identify antibiotic resistance?
mescreen™'s UAE wellness assessment is not presented as a test for antibiotic resistance or infection.
The current mescreen™ UAE product page describes an at-home mitochondrial function assessment using a dried blood spot sample and laboratory analysis, with the sample shipped to a partner laboratory in the United States. It explicitly describes the service as wellness profiling and not diagnostic.
That is a separate purpose from investigating an infection. The product description does not establish that the assessment identifies resistant bacteria, selects an antibiotic or explains why a medicine has not worked. No such capability is claimed here.
The same habit of asking what a test actually establishes is explored in our guide to food intolerance testing. Different question, same need to keep the measurement separate from the conclusion.
Limitations
This article explains evidence and terminology. It cannot determine whether symptoms are caused by bacteria or viruses, establish antibiotic resistance in an individual, or choose treatment.

The global findings are surveillance estimates with reporting gaps. The UAE self-medication study is historical and based on questionnaires. Neither is a current Dubai population prevalence survey, and neither validates a commercial wellness assessment for infection care.
For questions about symptoms or prescribed medicines, use a licensed UAE healthcare professional rather than a wellness questionnaire. For a separate, general look at mescreen™'s wellness offering, you can explore the free health check, without treating it as an infection assessment.
Sources
- WHO multi-country survey reveals widespread public misunderstanding about antibiotic resistance, World Health Organization, 2015.
- Antimicrobial resistance, World Health Organization, updated July 2026.
- MoHAP organises the 8th UAE International Conference on Antimicrobial Resistance, UAE Ministry of Health and Prevention, February 2025.
- WHO warns of widespread resistance to common antibiotics worldwide, World Health Organization, October 2025.
- Prevalence Of Self-Medication With Antibiotics Among Residents In United Arab Emirates, Abduelkarem and colleagues, Infection and Drug Resistance, 2019.
- Mescreen Mitochondrial Function Assessment, mescreen™ UAE.